More on ZBIO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.40 |
|
|||
| Open | $25.36 | ||||
| 52 Wk High | $50.95 | ||||
| 52 Wk Low | $18.06 | ||||
| Day High | $25.96 | ||||
| Day Low | $24.51 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 661,797 | ||||
- Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- H.C. Wainwright Reiterates Buy Rating on Zenas Biopharma (ZBIO)
- Form 8-K Zenas BioPharma, Inc. For: Oct 12
- Zenas BioPharma shares new obexelimab data for IgG4-RD treatment
- Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
- Zenas BioPharma to present MS drug data at MSToronto2026
- Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis
- Zenas BioPharma to Host Virtual R&D Event
- Zenas BioPharma to Host Virtual R&D Event
- Zenas Biopharma (ZBIO) PT Raised to $48 at Citi
Entities mentioned with ZBIO
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Show More...
